Aesthetics
Our scientists are working to find new, evidence-driven solutions focused on novel indications, improved delivery technologies and accelerated patient outcomes.
Decades after pioneering the field of aesthetic medicine, what’s next?
Our team is focused on creating products and technologies that advance aesthetic medicine. Conducting our own research, development and manufacturing, we seek to discover and accelerate comprehensive, science-based solutions that enhance people’s lives.
Data analytics, trends reporting and insight mining help us understand customer needs and allow us to deliver one of the largest, most-researched portfolio and pipeline in the medical aesthetics industry.
Scientists at our Irvine, California, R&D site advance the discovery and development of aesthetic medicines.
Scientists at our Irvine, California, R&D site advance the discovery and development ofaesthetic medicines
Research interests
We take an evidence-based approach to investigating the signs of aging and their underlying causes, building a portfolio of complementary, next-generation aesthetic solutions that aim to redefine the standard of care. Our pipeline is focused in three areas: neurotoxins, soft tissue fillers, and non-invasive body contouring. Our research interests include:
- Advancing the neurotoxin landscape, building on a decades-long legacy in both aesthetic and therapeutic uses, through prioritising novel indications and a diversified approach of unique formulations, serotypes and durations.
- Evolving the science around dermal fillers, developing novel injectables and seeking to address signs of aging caused by the loss of structural building blocks of skin and underlying skin tissues.
- Exploring meaningful advances in non-invasive body contouring for localised fat reduction, body sculpting, core strengthening and cellulite treatments, with potential growth areas in skin laxity and scar management.
Learn more about Allergan Aesthetics
UK-ABBV-260033 | February 2026
-
Leave the UK site?
You are now leaving the AbbVie UK corporate website and are being re-directed to an AbbVie UK corporate social media channel. This may contain links to external platforms outside of the control of AbbVie and for which AbbVie is not responsible.
-
Leave the UK site?
You are now leaving the AbbVie UK corporate website and are being re-directed to an AbbVie UK corporate social media channel. This may contain links to external platforms outside of the control of AbbVie and for which AbbVie is not responsible.
-
You are about to be redirected to an AbbVie site.
If you are a UK patient or healthcare professional contacting us with a Medical Information request, you can contact us via [email protected] or 01628 561092
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.
UK-ABBV-260001 | February 2026
